Cost-effectiveness analysis of a patient-centered care model for management of psoriasis

Parsi, Kory K.; Chambers, Cindy J.; Armstrong, April W.

doi:10.1016/j.jaad.2011.02.022

Cited by 63 publications

(61 citation statements)

References 36 publications

(41 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The literature search identified 19 articles and 1 abstract (published between 2003 and 2011), in which were described 7 cost-of-illness analyses [9,10,11,12,13,14,15], 1 cost-effectiveness analysis [16] and 13 cost-utility analyses [16,17,18,19,20,21,22,23,24,25,26,27,28]. …”

Section: Resultsmentioning

confidence: 99%

“…For psoriasis, while the time trade-off value proposed in the Catalog of Dermatology Utilities [33] was 0.91, EQ-5D values used in the reported studies were 0.71 [14], 0.77 [34] and 0.78 [24] using EQ-5D utility score and approximately 0.74 [23] and 59.08 [13] as measured by the EQ-5D VAS. In AD, the value proposed in the Catalog was 0.89 using time trade-off, in contrast to the mean EQ-5D values of 0.80 [20] and 0.72 [21].…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

The Role of the EQ-5D in the Economic Evaluation of Dermatological Conditions and Therapies

et al. 2012

View full text Add to dashboard Cite

Economic evaluation is an increasingly important aspect of assessment of the burden of skin diseases. Although dermatology data were not used in its development, the use of the EQ-5D questionnaire has been encouraged by the requirement of health technology assessment agencies for utility comparisons informing reimbursement decisions. The aim of this review was to examine the use of the EQ-5D in dermatology and to consider its future role in the economic evaluation of skin diseases. Published studies reporting the use of the EQ-5D in the economic analysis of skin diseases were carefully examined. Nineteen articles and 1 abstract published between 2003 and 2011 were identified, in which cost-of-illness, cost-effectiveness and cost-utility analyses were described. The EQ-5D is not a dermatology-specific measure, and it is not yet clear whether it is the most appropriate measure to support economic evaluation in the context of dermatology.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

The Role of the EQ-5D in the Economic Evaluation of Dermatological Conditions and Therapies

et al. 2012

View full text Add to dashboard Cite

show abstract

“…One innovative health care-delivery model in dermatology involves direct-access online care, with which patients can communicate directly with dermatologists and receive timely recommendations to manage their skin diseases. [18][19][20] This model may be especially suitable for managing chronic skin diseases, such as atopic dermatitis, for which regular follow-up care is necessary to control disease flares and maintain disease control.…”

mentioning

confidence: 99%

“…To be responsive to patient needs and to address challenges associated with consultative asynchronous teledermatology, it is valuable to evaluate novel technologyenabled specialty-care delivery models. Few studies [18][19][20] to date have examined the effect of direct-access online models on clinical outcomes in dermatology. The strengths of this study include its equivalency testing, randomized controlled equivalency design, and consistent follow-up with low dropout rate throughout the study.…”

mentioning

confidence: 99%

Patient-Centered, Direct-Access Online Care for Management of Atopic Dermatitis

Armstrong¹,

Johnson

Lin

et al. 2015

JAMA Dermatol

Self Cite

View full text Add to dashboard Cite

show abstract

“…The direct-care model has generally been practiced using S&F technology and in research settings (Chambers et al, 2010;Parsi et al, 2010;Watson et al, 2010).…”

Section: Direct-care Modelmentioning

confidence: 99%

Teledermatology: Outcomes and Economic Considerations

Pathipati¹,

Armstrong²

2011

Telemedicine Techniques and Applications

View full text Add to dashboard Cite

IntroductionTeledermatology is defined as the provision of dermatologic care through the use of communications technology (Goldyne & Armstrong, 2010). It offers many benefits that include increased access to dermatologic services and potential reduction in costs associated with care. Teledermatology is traditionally categorized into two different models based on the technology that is employed: store-and-forward (S&F) teledermatology, and live, interactive (LI) teledermatology (Goldyne & Armstrong, 2010). While hybrid models (a combination of S&F and LI technology) are practiced at selected institutions, this chapter focuses primarily on S&F and LI models. We will present operational flows of these two technology-enabled modalities, common outcomes measures used for evaluation of teledermatology quality metrics, and economic analyses. At the end of the chapter (in section 5), we will consider a novel, technology-independent framework for categorizing teledermatology models as well. This system relies on classification of teledermatology based on healthcare delivery models, and serves as an alternative way to organize and evaluate the provision of teledermatologic care. Store-and-forward teledermatologyStore-and-forward teledermatology is an asynchronous means for providing dermatologic care, as it relies on the asynchronous transmission of static digital images, patient histories, and specialist recommendations rather than real-time interaction between the specialist and the patient (Goldyne & Armstrong, 2010). In the S&F model, a medical staff personnel at the referral site typically takes images of the relevant skin condition and obtains medical history. This information is then sent to a dermatologist via a secure internet connection. The dermatologist evaluates the patient's condition asynchronously and transmits the recommendations back to the primary care provider at the referral site (Pak et al., 2009). Outcomes measures of store-and-forward teledermatologyTeledermatology studies have assessed numerous outcomes measures, including learning effects, length of consultation, and technical aspects (Eminovic et al., 2007). We will focus this discussion on four extensively used outcomes measures: diagnostic accuracy, diagnostic reliability, clinical outcomes, and satisfaction.

show abstract

Cost-effectiveness analysis of a patient-centered care model for management of psoriasis

Cited by 63 publications

References 36 publications

The Role of the EQ-5D in the Economic Evaluation of Dermatological Conditions and Therapies

The Role of the EQ-5D in the Economic Evaluation of Dermatological Conditions and Therapies

Patient-Centered, Direct-Access Online Care for Management of Atopic Dermatitis

Teledermatology: Outcomes and Economic Considerations

Contact Info

Product

Resources

About